TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Opioids Market - Key Market Dynamics

4.1 North America Opioids Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Surging Chronic Pain Incidence

4.2.2 Increasing Geriatric Population

4.3 Market Restraints

4.3.1 Increasing Drug Abuse

4.4 Market Opportunities

4.4.1 Strategic Initiatives by Market Players

4.5 Future Trends

4.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder

4.6 Impact of Drivers and Restraints:

5. Opioids Market - North America Analysis

5.1 North America Opioids Market Revenue (US$ Million), 2020-2030

5.2 North America Opioids Market Forecast Analysis

6. North America Opioids Market Analysis - by Product

6.1 Immediate Release Short Acting Opioid

6.1.1 Overview

6.1.2 Immediate Release Short Acting Opioid: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.1.2.1 North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

6.2 Extended Release Long-Acting Opioid

6.2.1 Overview

6.2.2 Extended Release Long-Acting Opioid: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.2.2.1 North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. North America Opioids Market Analysis - by Application

7.1 Pain Management

7.1.1 Overview

7.1.2 Pain Management: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Anesthesia

7.2.1 Overview

7.2.2 Anesthesia: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Diarrhea Suppression

7.3.1 Overview

7.3.2 Diarrhea Suppression: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cough Suppression

7.4.1 Overview

7.4.2 Cough Suppression: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.5 De-Addiction

7.5.1 Overview

7.5.2 De-Addiction: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Opioids Market Analysis - by Route of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Injectable

8.2.1 Overview

8.2.2 Injectable: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Transdermal Patch

8.3.1 Overview

8.3.2 Transdermal Patch: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Opioids Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview

9.1.2 Hospital Pharmacies: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview

9.2.2 Retail Pharmacies: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Opioids Market - Country Analysis

10.1 North America Opioids Market - Country Analysis

10.1.1 North America Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

10.1.1.1 North America Opioids Market - Revenue and Forecast Analysis - by Country

10.1.1.2 United States: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 United States: North America Opioids Market Breakdown, by Product

10.1.1.2.2 United States: North America Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.2.3 United States: North America Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.2.4 United States: North America Opioids Market Breakdown, by Application

10.1.1.2.5 United States: North America Opioids Market Breakdown, by Route of Administration

10.1.1.2.6 United States: North America Opioids Market Breakdown, by Distribution Channel

10.1.1.3 Canada: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Canada: North America Opioids Market Breakdown, by Product

10.1.1.3.2 Canada: North America Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.3.3 Canada: North America Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.3.4 Canada: North America Opioids Market Breakdown, by Application

10.1.1.3.5 Canada: North America Opioids Market Breakdown, by Route of Administration

10.1.1.3.6 Canada: North America Opioids Market Breakdown, by Distribution Channel

10.1.1.4 Mexico: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Mexico: North America Opioids Market Breakdown, by Product

10.1.1.4.2 Mexico: North America Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.4.3 Mexico: North America Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.1.4.4 Mexico: North America Opioids Market Breakdown, by Application

10.1.1.4.5 Mexico: North America Opioids Market Breakdown, by Route of Administration

10.1.1.4.6 Mexico: North America Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Opioids Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Purdue Pharma L.P.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Endo International plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Mallinckrodt Plc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Collegium Pharmaceutical, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Neuraxpharm Pharmaceuticals SL

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Hikma Pharmaceuticals Plc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Rusan Pharma Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Trevena, Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Teva Pharmaceutical Industries Ltd

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. North America Opioids Market Segmentation

Table 2. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 5. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 6. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 7. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 8. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 9. North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country

Table 10. United States: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 11. United States: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 12. United States: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 13. United States: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 14. United States: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 15. United States: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 16. Canada: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 17. Canada: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 18. Canada: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 19. Canada: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 20. Canada: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 21. Canada: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 22. Mexico: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 23. Mexico: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 24. Mexico: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 25. Mexico: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 26. Mexico: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 27. Mexico: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 28. Recent Organic Growth Strategies in Opioids Market

Table 29. Recent Inorganic Growth Strategies in the Opioids Market

Table 30. Glossary of Terms, Opioids Market

List of Figures

Figure 1. North America Opioids Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. North America Opioids Market Revenue (US$ Million), 2020-2030

Figure 4. North America Opioids Market Share (%) - by Product (2022 and 2030)

Figure 5. Immediate Release Short Acting Opioid: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Extended Release Long-Acting Opioid: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. North America Opioids Market Share (%) - by Application (2022 and 2030)

Figure 8. Pain Management: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Anesthesia: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Diarrhea Suppression: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Cough Suppression: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. De-Addiction: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Others: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. North America Opioids Market Share (%) - by Route of Administration (2022 and 2030)

Figure 15. Oral: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Injectable: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Transdermal Patch: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. North America Opioids Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 19. Hospital Pharmacies: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Retail Pharmacies: North America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. North America Opioids Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)

Figure 22. North America Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 23. United States: North America Opioids Market - Revenue and Forecast to 2030(US$ Million)

Figure 24. Canada: North America Opioids Market - Revenue and Forecast to 2030(US$ Million)

Figure 25. Mexico: North America Opioids Market - Revenue and Forecast to 2030(US$ Million)

Figure 26. Growth Strategies in Opioids Market